Quantifying The Contribution Of Hosts With Diff...

Conquering Methicillin Resistant Staphylococcus...

Lyme Borreliosis Transmission

Pmqr Determinants Among Clinical Isolates Of Es...

A Novel Binary Biofilm Model For The Study Of T...

0 votes
Clinical Efficacy Of Fosfomycin For The Treatment Of Complicated Lower Tract And Uncomplicated Urinary Tract Infections
Author: Jerod L. Nagel, Laraine Washer, Anjly Kunapuli, Jennifer Heidmann, Jennifer Pisani, Tejal Gandhi
Publisher: Internet Medical Publishing
7 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
DOI: 10.3823/1750
Follow this publisher

Share this publication:


In recent years, multi-drug resistant (MDR) urinary tract infections (UTI) caused by extended spectrum β-lactamase (ESBL) producing Enterobacteriaceae and vancomycin-resistant Enterococci (VRE) have become more prevalent. [1-3] Due to high resistance rates to oral antibiotics, VRE and ESBL UTIs are commonly treated with intravenous antibiotics which are more expensive and inconvenient for patients.

About the publisher:

iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.

Select a payment method